Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million. The…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now